Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Other Non-Current Liabilities (2016 - 2022)

Nutex Health (NUTX) has disclosed Other Non-Current Liabilities for 6 consecutive years, with $3.1 million as the latest value for Q1 2022.

  • For Q1 2022, Other Non-Current Liabilities changed N/A year-over-year to $3.1 million; the TTM value through Mar 2022 reached $3.1 million, changed N/A, while the annual FY2018 figure was $288242.0, 336.34% up from the prior year.
  • Other Non-Current Liabilities hit $3.1 million in Q1 2022 for Nutex Health, up from $219516.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $3.1 million in Q1 2022 and bottomed at $33473.0 in Q2 2018.
  • Average Other Non-Current Liabilities over 3 years is $772018.0, with a median of $227287.0 recorded in 2018.
  • On a YoY basis, Other Non-Current Liabilities climbed as much as 336.34% in 2018 and fell as far as 336.34% in 2018.
  • Nutex Health's Other Non-Current Liabilities stood at $288242.0 in 2018, then decreased by 23.84% to $219516.0 in 2019, then skyrocketed by 1308.36% to $3.1 million in 2022.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $3.1 million, $219516.0, and $288242.0 for Q1 2022, Q1 2019, and Q4 2018 respectively.